222 related articles for article (PubMed ID: 10440750)
1. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
Morii K; Tanaka R; Onda K; Tsumanuma I; Yoshimura J
Biochem Biophys Res Commun; 1997 Oct; 239(3):830-4. PubMed ID: 9367854
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
4. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in microdissected human gliomas.
Weil RJ; Wu YY; Vortmeyer AO; Moon YW; Delgado RM; Fuller BG; Lonser RR; Remaley AT; Zhuang Z
Mod Pathol; 1999 Jan; 12(1):41-6. PubMed ID: 9950161
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
Maes L; Kalala JP; Cornelissen R; de Ridder L
Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
[TBL] [Abstract][Full Text] [Related]
7. Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.
Glanz C; Rebetz J; Stewénius Y; Persson A; Englund E; Mandahl N; Mertens F; Salford LG; Widegren B; Fan X; Gisselsson D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):440-54. PubMed ID: 17617873
[TBL] [Abstract][Full Text] [Related]
8. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
Kasai H; Kawamoto K
Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
[TBL] [Abstract][Full Text] [Related]
9. Analysis of telomerase activity and telomere function in cancer.
Gordon KE; Parkinson EK
Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
[TBL] [Abstract][Full Text] [Related]
10. Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
Chen HJ; Liang CL; Lu K; Lin JW; Cho CL
Cancer; 2000 Nov; 89(10):2092-8. PubMed ID: 11066050
[TBL] [Abstract][Full Text] [Related]
11. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
12. Telomeres, telomerase and cancer: is the magic bullet real?
Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
Kafadar AM; Ergen A; Zeybek U; Agachan B; Kuday C; Isbir T
Cell Biochem Funct; 2006; 24(5):455-60. PubMed ID: 16142697
[TBL] [Abstract][Full Text] [Related]
14. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
16. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
[TBL] [Abstract][Full Text] [Related]
17. Multiple pathways for the regulation of telomerase activity.
Holt SE; Wright WE; Shay JW
Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
19. Telomerase in brain tumors.
Falchetti ML; Larocca LM; Pallini R
Childs Nerv Syst; 2002 Apr; 18(3-4):112-7. PubMed ID: 11981616
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]